Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Change in Account Payables (2017 - 2020)

enVVeno Medical has reported Change in Account Payables over the past 4 years, most recently at $416133.0 for Q4 2020.

  • For Q4 2020, Change in Account Payables rose 4119.56% year-over-year to $416133.0; the TTM value through Dec 2020 reached $169173.0, up 17.43%, while the annual FY2023 figure was -$221000.0, 351.14% down from the prior year.
  • Change in Account Payables for Q4 2020 was $416133.0 at enVVeno Medical, up from -$593127.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $416133.0 in Q4 2020 and troughed at -$593127.0 in Q3 2020.
  • A 4-year average of $22509.3 and a median of $16589.0 in 2019 define the central range for Change in Account Payables.
  • On a YoY basis, Change in Account Payables climbed as much as 4119.56% in 2020 and fell as far as 4209.24% in 2020.
  • Year by year, Change in Account Payables stood at $321010.0 in 2017, then plummeted by 145.33% to -$145504.0 in 2018, then soared by 106.78% to $9862.0 in 2019, then soared by 4119.56% to $416133.0 in 2020.
  • Business Quant data shows Change in Account Payables for NVNO at $416133.0 in Q4 2020, -$593127.0 in Q3 2020, and $169550.0 in Q2 2020.